Jesús Lovera

1.5k total citations
33 papers, 1.2k citations indexed

About

Jesús Lovera is a scholar working on Pathology and Forensic Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Jesús Lovera has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 13 papers in Neurology and 4 papers in Infectious Diseases. Recurrent topics in Jesús Lovera's work include Multiple Sclerosis Research Studies (20 papers), Long-Term Effects of COVID-19 (6 papers) and Peripheral Neuropathies and Disorders (3 papers). Jesús Lovera is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Long-Term Effects of COVID-19 (6 papers) and Peripheral Neuropathies and Disorders (3 papers). Jesús Lovera collaborates with scholars based in United States, Slovakia and Canada. Jesús Lovera's co-authors include Dennis Bourdette, Vijayshree Yadav, Deidre Devier, Ruth H. Whitham, Gail Marracci, Walter J. Lukiw, Cynthia D. Morris, Michelle Cameron, Barry Oken and Bridget Bagert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and The FASEB Journal.

In The Last Decade

Jesús Lovera

31 papers receiving 1.1k citations

Peers

Jesús Lovera

PFM

NEURO

PMH

IMMUN

Amirreza Azimi Iran

Miguel Ángel Macías-Islas Mexico

Zisis Tsouris Greece

Mehrdokht Mazdeh Iran

Maria Anagnostouli Greece

Cecília Rajda Hungary

Josiane Lopes Brazil

Yuguang Guan China

Malte Christian Claussen Switzerland

Yuan Fang China

Amirreza Azimi Iran

Jesús Lovera

554 ×0.8

PFM

325 ×1.3

215 ×0.9

NEURO

151 ×0.9

PMH

92 ×0.8

IMMUN

Citations per year, relative to Jesús Lovera Jesús Lovera (= 1×) peers Amirreza Azimi

Countries citing papers authored by Jesús Lovera

Since Specialization

Citations

This map shows the geographic impact of Jesús Lovera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Lovera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Lovera more than expected).

Fields of papers citing papers by Jesús Lovera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Lovera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Lovera. The network helps show where Jesús Lovera may publish in the future.

Co-authorship network of co-authors of Jesús Lovera

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Lovera. A scholar is included among the top collaborators of Jesús Lovera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Lovera. Jesús Lovera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lovera, Jesús, et al.. (2025). A single Center study of the Symbol Digit Modalities test as a screening tool for cognitive impairment in Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 13. 100395–100395.

Lovera, Jesús, et al.. (2023). Cytomegalovirus and varicella zoster virus coinfection-associated central hypoventilation syndrome (Ondine's Curse). eNeurologicalSci. 34. 100488–100488. 1 indexed citations

Lovera, Jesús, et al.. (2022). Autoimmune Myelitis and Myocarditis in a Patient With Anti-Aquaporin-4, Antinuclear, and Antiphospholipid Autoantibodies: The Neuromyelitis Optica-Systemic Lupus Erythematosus (NMO-SLE) Overlap Syndrome. Cureus. 14(11). e31334–e31334. 2 indexed citations

Villemarette-Pittman, Nicole R., et al.. (2021). Altered mental status predicts length of stay but not death in a community-based cohort of hospitalized COVID-19 patients. Clinical Neurology and Neurosurgery. 210. 106977–106977. 2 indexed citations

Xiang, Xinran, et al.. (2020). Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Recurrent and Migrating Focal Cortical Encephalitis. SHILAP Revista de lepidopterología. 7. 2329048X2096617–2329048X2096617. 4 indexed citations

Lukiw, Walter J., et al.. (2020). A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways. Journal of the Neurological Sciences. 420. 117202–117202. 20 indexed citations

Yadav, Vijayshree, Gail Marracci, Edward Kim, et al.. (2016). Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Multiple Sclerosis and Related Disorders. 9. 80–90. 115 indexed citations

Lovera, Jesús, Deidre Devier, Dennis R. Koop, et al.. (2015). Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies. Journal of the Neurological Sciences. 358(1-2). 46–52. 53 indexed citations

Hughes, Abbey J., Narineh Hartoonian, Brett A. Parmenter, et al.. (2015). Cognitive Impairment and Community Integration Outcomes in Individuals Living With Multiple Sclerosis. Archives of Physical Medicine and Rehabilitation. 96(11). 1973–1979. 19 indexed citations

10.

Gutierrez, Amparo, et al.. (2015). Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?. Journal of the Neurological Sciences. 349(1-2). 239–242. 2 indexed citations

11.

Devier, Deidre, Jesús Lovera, & Walter J. Lukiw. (2015). Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration. Frontiers in Molecular Neuroscience. 8. 5–5. 58 indexed citations

12.

Yadav, Vijayshree, Gail Marracci, Edward Kim, et al.. (2014). Effects of a Low Fat Plant Based Diet in Multiple Sclerosis (MS): Results of a 1- Year Long Randomized Controlled (RC) Study (P6.152). Neurology. 82(10_supplement). 4 indexed citations

13.

Lovera, Jesús, Edward Kim, Mary Anne Fitzpatrick, et al.. (2012). Ginkgo biloba does not improve cognitive function in MS. Neurology. 79(12). 1278–1284. 40 indexed citations

14.

Lovera, Jesús, et al.. (2012). Cognitive Impairment in Multiple Sclerosis. Current Neurology and Neuroscience Reports. 12(5). 618–627. 111 indexed citations

15.

Kim, Edward, et al.. (2010). Novel method for measurement of fatigue in multiple sclerosis: Real-Time Digital Fatigue Score. The Journal of Rehabilitation Research and Development. 47(5). 477–477. 48 indexed citations

16.

Yadav, Vijayshree, et al.. (2010). Clinical trial of a formal group fatigue program in multiple sclerosis. Multiple Sclerosis Journal. 16(6). 724–732. 44 indexed citations

17.

Vandenbark, Arthur A., Nicole Culbertson, Richard M. Bartholomew, et al.. (2007). Therapeutic vaccination with a trivalent T‐cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis. Immunology. 123(1). 66–78. 59 indexed citations

18.

Oken, Barry, Kristin E. Flegal, Daniel P. Zajdel, et al.. (2006). Cognition and fatigue in multiple sclerosis: Potential effects of medications with central nervous system activity. The Journal of Rehabilitation Research and Development. 43(1). 83–83. 32 indexed citations

19.

Lovera, Jesús, Bridget Bagert, Katherine Wild, et al.. (2006). Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests. The Journal of Rehabilitation Research and Development. 43(1). 73–73. 56 indexed citations

20.

Bourdette, Dennis, E.V.J. Edmonds, Cassandra Smith, et al.. (2005). A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. Multiple Sclerosis Journal. 11(5). 552–561. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact